Stage IIIA Breast Cancer Terminated Phase 1 Trials for RG-4733 (DB11870)

IndicationStatusPhase
DBCOND0028774 (Stage IIIA Breast Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01208441RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast CancerTreatment
NCT01238133Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast CancerTreatment